ABACAVIR AND LAMIVUDINE - abacavir and lamivudine tablet, film coated 
Aurobindo Pharma Limited

----------

MEDICATION GUIDE

Abacavir and Lamivudine Tablets USP

(a bak' a vir and la miv' ue deen)

What is the most important information I should know about abacavir and lamivudine tablets?

Abacavir and lamivudine tablets can cause serious side effects, including:


If you get a symptom from 2 or more of the following groups while taking abacavir and lamivudine tablets, call your healthcare provider right away to find out if you should stop taking abacavir and lamivudine tablets.   

Symptom(s)
Group 1
Fever
Group 2
Rash
Group 3
Nausea, vomiting, diarrhea, abdominal (stomach area) pain
Group 4
Generally ill feeling, extreme tiredness, or achiness
Group 5
Shortness of breath, cough, sore throat

A list of these symptoms is on the Warning Card your pharmacist gives you. Carry this Warning Card with you at all times.            


If you stop abacavir and lamivudine tablets because of an allergic reaction, never take abacavir and lamivudine tablets or any other abacavir-containing medicine (TRIUMEQ, TRIZIVIR, or ZIAGEN) again.


If your healthcare provider tells you that you can take abacavir and lamivudine tablets again, start taking them when you are around medical help or people who can call a healthcare provider if you need one.


What are abacavir and lamivudine tablets?


Abacavir and lamivudine tablets are a prescription medicine used with other HIV-1 medicines to treat HIV-1 infection.


HIV-1 is the virus that causes Acquired Immune Deficiency Syndrome (AIDS).


Abacavir and lamivudine tablets contain the prescription medicines abacavir and lamivudine.


Abacavir and lamivudine tablets should not be used in children weighing less than 55 pounds (25 kg).


Do not take abacavir and lamivudine tablets if you:

Before you take abacavir and lamivudine tablets tell your healthcare provider about all of your medical conditions, including if you:

Pregnancy Registry. There is a pregnancy registry for women who take HIV-1 medicines during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. Talk to your healthcare provider about how you can take part in this registry.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.


Some medicines interact with abacavir and lamivudine tablets. Keep a list of your medicines to show your healthcare provider and pharmacist when you get a new medicine.

How should I take abacavir and lamivudine tablets?

What are the possible side effects of abacavir and lamivudine tablets?

You may be more likely to get lactic acidosis or serious liver problems if you are female or very overweight (obese).

The most common side effects of abacavir and lamivudine tablets include:

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.


These are not all the possible side effects of abacavir and lamivudine tablets. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


How should I store abacavir and lamivudine tablets?

Keep abacavir and lamivudine tablets and all medicines out of the reach of children.


General information for safe and effective use of abacavir and lamivudine tablets.


Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use abacavir and lamivudine tablets for a condition for which it was not prescribed. Do not give abacavir and lamivudine tablets to other people, even if they have the same symptoms that you have. They may harm them. You can ask your healthcare provider or pharmacist for the information about abacavir and lamivudine tablets that is written for health professionals.


What are the ingredients in abacavir and lamivudine tablets?


Active ingredients: abacavir sulfate and lamivudine


Inactive ingredients: magnesium stearate, microcrystalline cellulose and sodium starch glycolate.


Tablet film coating contains: Opadry Orange YS-1-13065-A that is made of FD&C yellow #6 aluminum lake, hypromellose, polyethylene glycol 400, polysorbate 80, and titanium dioxide.

Distributed by:
Aurobindo Pharma USA, Inc.
279 Princeton-Hightstown Road
East Windsor, NJ 08520

Manufactured by:
Aurobindo Pharma Limited
Hyderabad-500 032, India

EPIVIR, TRIUMEQ, TRIZIVIR, and ZIAGEN are trademarks owned by or licensed to the ViiV Healthcare group of companies.


The other brands listed are trademarks owned by or licensed to their respective owners and are not trademarks owned by or licensed to the Aurobindo Pharma Limited. The makers of these brands are not affiliated with and do not endorse the Aurobindo Pharma Limited or its products.


For more information call Aurobindo Pharma USA, Inc at 1-866-850-2876.


This Medication Guide has been approved by the U.S. Food and Drug Administration.

Revised: 01/2022

Revised: 5/2024
Aurobindo Pharma Limited